BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $622,330 | -9.1% | 12,210 | -3.9% | 0.06% | -17.4% |
| Q3 2022 | $685,000 | -50.3% | 12,711 | -40.7% | 0.07% | -49.3% |
| Q2 2022 | $1,377,000 | -33.7% | 21,431 | -19.9% | 0.14% | -20.0% |
| Q1 2022 | $2,076,000 | -9.7% | 26,771 | -0.1% | 0.17% | -4.0% |
| Q4 2021 | $2,299,000 | +6.5% | 26,787 | -0.1% | 0.18% | +29.2% |
| Q3 2021 | $2,158,000 | -1.6% | 26,822 | -1.5% | 0.14% | -3.5% |
| Q2 2021 | $2,192,000 | -5.1% | 27,222 | -0.5% | 0.14% | -7.8% |
| Q1 2021 | $2,309,000 | +0.7% | 27,372 | -4.2% | 0.15% | -2.5% |
| Q4 2020 | $2,293,000 | +1.6% | 28,577 | +1.9% | 0.16% | -8.1% |
| Q3 2020 | $2,256,000 | -4.0% | 28,047 | +2.8% | 0.17% | -13.1% |
| Q2 2020 | $2,349,000 | +4.6% | 27,282 | -1.4% | 0.20% | -32.0% |
| Q1 2020 | $2,246,000 | -3.5% | 27,657 | -0.6% | 0.29% | +22.3% |
| Q4 2019 | $2,328,000 | -6.5% | 27,832 | -2.2% | 0.24% | -10.2% |
| Q3 2019 | $2,489,000 | +6.1% | 28,465 | -0.7% | 0.26% | -29.0% |
| Q2 2019 | $2,347,000 | +9.1% | 28,665 | +8.3% | 0.37% | +7.5% |
| Q1 2019 | $2,151,000 | +31.2% | 26,460 | +6.2% | 0.35% | +10.2% |
| Q4 2018 | $1,639,000 | -15.9% | 24,911 | -1.5% | 0.32% | -1.6% |
| Q3 2018 | $1,950,000 | +11.5% | 25,286 | +6.8% | 0.32% | +5.3% |
| Q2 2018 | $1,749,000 | +14.0% | 23,686 | +0.4% | 0.30% | +17.8% |
| Q1 2018 | $1,534,000 | -12.2% | 23,586 | -12.8% | 0.26% | -13.4% |
| Q4 2017 | $1,748,000 | -16.5% | 27,036 | -19.0% | 0.30% | -17.7% |
| Q3 2017 | $2,093,000 | +48.3% | 33,361 | +43.1% | 0.36% | -7.2% |
| Q2 2017 | $1,411,000 | +16.8% | 23,306 | 0.0% | 0.39% | +16.1% |
| Q1 2017 | $1,208,000 | +17.9% | 23,306 | +0.8% | 0.34% | +10.5% |
| Q4 2016 | $1,025,000 | -7.1% | 23,131 | -0.2% | 0.30% | -14.1% |
| Q3 2016 | $1,103,000 | +2.4% | 23,181 | -2.6% | 0.35% | -0.3% |
| Q2 2016 | $1,077,000 | -18.1% | 23,806 | -25.7% | 0.36% | -23.8% |
| Q1 2016 | $1,315,000 | +7.8% | 32,019 | +0.1% | 0.47% | +8.4% |
| Q4 2015 | $1,220,000 | +40.4% | 31,994 | +20.9% | 0.43% | +38.7% |
| Q3 2015 | $869,000 | -64.7% | 26,469 | -24.7% | 0.31% | -59.6% |
| Q2 2015 | $2,459,000 | +0.9% | 35,166 | -1.1% | 0.77% | +2.1% |
| Q1 2015 | $2,436,000 | -4.8% | 35,556 | +1.8% | 0.75% | -6.1% |
| Q4 2014 | $2,560,000 | +0.5% | 34,926 | -1.6% | 0.80% | -1.6% |
| Q3 2014 | $2,547,000 | -0.9% | 35,494 | -0.2% | 0.81% | +1.6% |
| Q2 2014 | $2,570,000 | -22.4% | 35,560 | -20.9% | 0.80% | -25.0% |
| Q1 2014 | $3,310,000 | +12.1% | 44,983 | +5.9% | 1.07% | +10.1% |
| Q4 2013 | $2,953,000 | +1.2% | 42,472 | -4.4% | 0.97% | -1.9% |
| Q3 2013 | $2,919,000 | -7.5% | 44,441 | -2.4% | 0.99% | -11.7% |
| Q2 2013 | $3,155,000 | – | 45,541 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |